AISP vs HIT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AISP exhibits severe financial health concerns, with a Piotroski F-Score of 2/9 indicating high distress risk and no Altman Z-Score available, which raises red flags for potential bankruptcy. Despite strong revenue growth of 102.5% YoY and a high gross margin of 50.24%, the company reports a negative operating margin (-9.44%) and ROA of -27.18%, signaling poor operational efficiency. The stock trades at a P/E of 3.46 but has a forward P/E of 17.53, suggesting overvaluation relative to future earnings expectations. Analysts have only one coverage, with a target price of $8.00, but the company has consistently missed earnings estimates, with an average surprise of -358% over the last four quarters.
HIT presents a high-risk profile characterized by a Piotroski F-Score of 4/9 (Stable) but severe technical deterioration. While the company exhibits strong revenue growth (53.10%) and an exceptionally clean balance sheet (Debt/Equity 0.01), it is trading at a massive premium to its Graham Number ($0.37) and Intrinsic Value ($0.14). The stock is currently in a freefall with a 0/100 technical trend and a 60.8% decline over the last six months, coupled with a poor earnings track record of 0/4 beats.
Compare Another Pair
Related Comparisons
AISP vs HIT: Head-to-Head Comparison
This page compares Airship AI Holdings, Inc. (AISP) and Health In Tech, Inc. (HIT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.